Dr. Slade Matthews is a Senior Lecturer specializing in computational pharmacology and toxicology. His research focuses on predicting chemical properties and bioactivity using Python-based QSAR models and cheminformatic techniques such as molecular fingerprinting, quantum molecular calculations, clustering, and substructure analysis. He earned his PhD in 2007 on machine learning in biomedical data and has published 48 peer-reviewed papers (Scopus h-index: 18). In 2025 Slade published a state-of-the-art graph transformer-based QSAR model for Ames mutagenicity prediction. He serves on the TGA Medical and Scientific Evaluation Services Panel and the NSW Poisons Advisory Committee both since 2010. In 2024, he was elected to the ASCEPT Board and awarded Fellowship of ACTRA in 2025. Based at the University of Sydney, Slade collaborates with academic and regulatory partners to advance public safety through application of in silico toxicology and is passionate about mentoring students and interdisciplinary research bridging chemistry, biology, and data science.

Professor Janet Mifsud de Gray PhD, is Head, Department of Clinical Pharmacology and Therapeutics, University of Malta. Her area of expertise is in the pharmacology of medicines used in chronic neurological disorders especially epilepsy, ethical and bioethical issues in health care, pharmacotoxicology, and education in pharmacology. She has published extensively in her area of expertise. She was a Fulbright Scholar and DAAD awardee. She is member of the IUPHAR Education Council and has been involved in several EU and internationally funded projects. She is Fellow of the British Pharmacological Society in 2017, former Vice-President (Europe) International Bureau for Epilepsy. and Ambassador for the International League Against Epilepsy.

Prof Prafull Mohan is a clinical Pharmacologist working in India. He is involved in clinical ersearch that centres around metabolic syndrome, pharmacovigilance and health tech applications. With 0ver 15 years of experience, he has guided students for their thesis and also for research projects.

Dr Musgrave is a molecular pharmacologist/toxicologist. He obtained his PhD from the University of Melbourne in 1989, postdoctoral work in the Institute of Pharmacology at the Free University of Berlin in 1991-1994, returning to Australia in 1994 on a CJ Martin Fellowship. He was appointed as Senior Lecturer in Pharmacology at the University of Adelaide in 2001. He has a broad interest in neuronal function and survival, natural product pharmacology and drug design. Current research focuses on the safety of herbal medicines and natural products as potential anti-amyloid medications. Ian has consulted with the State Health and the TGA on the safety of herbal medicine.

Katarzyna Palus is an Associate Professor in the Department of Clinical Physiology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Poland. Her research focuses on veterinary toxicology and the effects of environmental factors on the digestive and reproductive systems, with particular emphasis on neural regulatory mechanisms. She has authored approximately 50 scientific and popular science publications. Her work combines experimental physiology, neurobiology, and toxicology to better understand how low-dose environmental contaminants influence organ function and neurochemical regulation in animals. Her current research includes studies on the impact of glyphosate exposure on neuropeptide signaling and innervation patterns in the reproductive tract. Katarzyna Palus teaches physiology to veterinary students and supervises PhD candidates, contributing to the education of future researchers and clinicians in animal and comparative biomedical sciences.

Clinical Pharmacy PhD, Master's Supervisor Deputy Director, Clinical Pharmacy Subspecialty, Zhongshan Hospital, Fudan University Head of Pharmacy Department, Zhongshan Hospital (Xiamen), Fudan University Shanghai "New Star of Medicine" Young Medical Talent; Young Talent of the Chinese Pharmaceutical Association; Young Talent of the Shanghai Pharmaceutical Association Scholar of the Harvard Global Clinical Scholars Research Training Program First/Corresponding author of 14 SCI papers and 10 core Chinese journal papers Principal investigator of 12 research projects, including grants from the National Natural Science Foundation of China etc. Standing Committee Member and Secretary of the Youth Committee, Therapeutic Drug Monitoring Research Committee, Chinese Pharmacological Society; Youth Committee Member, Drug-induced Diseases Committee, Shanghai Pharmaceutical Association Recipient of honors including the Top Ten "2022 Patient Safety Goal Practice Typical Cases" by the Chinese Hospital Association for pharmaceutical care case; the 2021 "Pharmacy Elite" Award by the Clinical Pharmacy Branch of Shanghai Medical Association.

Clinical Pharmacy PhD, Master's Supervisor Deputy Director, Clinical Pharmacy Subspecialty, Zhongshan Hospital, Fudan University Head of Pharmacy Department, Zhongshan Hospital (Xiamen), Fudan University Shanghai "New Star of Medicine" Young Medical Talent; Young Talent of the Chinese Pharmaceutical Association; Young Talent of the Shanghai Pharmaceutical Association Scholar of the Harvard Global Clinical Scholars Research Training Program First/Corresponding author of 14 SCI papers and 10 core Chinese journal papers Principal investigator of 12 research projects, including grants from the National Natural Science Foundation of China etc. Standing Committee Member and Secretary of the Youth Committee, Therapeutic Drug Monitoring Research Committee, Chinese Pharmacological Society; Youth Committee Member, Drug-induced Diseases Committee, Shanghai Pharmaceutical Association Recipient of honors including the Top Ten "2022 Patient Safety Goal Practice Typical Cases" by the Chinese Hospital Association for pharmaceutical care case; the 2021 "Pharmacy Elite" Award by the Clinical Pharmacy Branch of Shanghai Medical Association.

Clinical Pharmacy PhD, Master's Supervisor Deputy Director, Clinical Pharmacy Subspecialty, Zhongshan Hospital, Fudan University Head of Pharmacy Department, Zhongshan Hospital (Xiamen), Fudan University Shanghai "New Star of Medicine" Young Medical Talent; Young Talent of the Chinese Pharmaceutical Association; Young Talent of the Shanghai Pharmaceutical Association Scholar of the Harvard Global Clinical Scholars Research Training Program First/Corresponding author of 14 SCI papers and 10 core Chinese journal papers Principal investigator of 12 research projects, including grants from the National Natural Science Foundation of China etc. Standing Committee Member and Secretary of the Youth Committee, Therapeutic Drug Monitoring Research Committee, Chinese Pharmacological Society; Youth Committee Member, Drug-induced Diseases Committee, Shanghai Pharmaceutical Association Recipient of honors including the Top Ten "2022 Patient Safety Goal Practice Typical Cases" by the Chinese Hospital Association for pharmaceutical care case; the 2021 "Pharmacy Elite" Award by the Clinical Pharmacy Branch of Shanghai Medical Association.

Chin Hang (Benson) is a PhD candidate at the Sydney Pharmacy School. His primary areas of research interest include clinical pharmacy, pharmacoepidemiology and health services research. He is also a registered pharmacist with experience in both community and hospital pharmacy.

Kim SuJin is a master’s student at The Catholic University of Korea. She holds a Bachelor of Pharmacy degree and is currently pursuing graduate training in clinical pharmacy. Her research interests focus on pharmacoepidemiology using real-world big data, regulatory science, and pharmacovigilance. Her ongoing research includes an analysis of fentanyl utilization patterns using nationwide healthcare databases in Korea, as well as the investigation of adverse drug reactions associated with CDK inhibitors using global spontaneous reporting systems such as FAERS and VigiBase. Through her work, she aims to contribute to evidence-based drug safety evaluation and regulatory decision-making.

Sally Babiker is a second-year PhD student in the Clinical Pharmacology and Therapeutics Group at University College London, School of Pharmacy. Her research focuses on the optimisation of drug dosing in paediatric populations. In particular, her doctoral research investigates pharmacokinetic-pharmacodynamic relationships and dose rationale for antitubercular drug combinations in children with pulmonary and extrapulmonary tuberculosis, with the aim of improving treatment efficacy and supporting safer, shorter treatment regimens. Her broader research interests include model-informed drug development, paediatric clinical pharmacology, and quantitative approaches to dose optimisation across therapeutic areas, including chronic kidney disease. Prior to commencing her PhD, Sally obtained a BSc in Biomedical Sciences from King’s College London and an MSc in Clinical Drug Development from University College London.

With 18 years of clinical experience, she is an interventional specialist nurse and serves as the clinical team leader of the department. She has obtained one utility model patent and published two articles in core journals.

Huang Chunlan, female, Senior Nurse, holds a bachelor's degree. She graduated from Chongqing Medical College in 2009 and has worked in the Department of Infectious Diseases for over 15 years. During her career, she continuously pursued further education and obtained both a nursing associate degree and a bachelor's degree. In 2021, she was awarded the title of "Outstanding Nursing Worker" by Dianjiang County for the year 2020. In 2023, she received the "Nursing Service Star" award from Dianjiang County People's Hospital. In 2024, she was honored as the county-level "Most Beautiful Nurse" in Dianjiang County and has been repeatedly recognized as an "Excellent Nurse" by Dianjiang County People's Hospital. In terms of talent development, she has mentored over 50 interns and more than 10 standardized training residents.

Dr. Sanjay Khattri is a Professor of Pharmacology at King George’s Medical University (KGMU), Lucknow, with over two decades of experience in academic medicine, clinical pharmacology, and translational research. He completed his MBBS and MD (Pharmacology) at King George’s Medical College. His expertise lies in clinical and molecular pharmacology, with a research focus on metabolic syndrome, type 2 diabetes mellitus, aging, neurodegeneration, and cancer biology. He has led multiple nationally funded projects supported by the Indian Council of Medical Research (ICMR), the Council of Scientific and Industrial Research (CSIR), the Research Society for the Study of Diabetes in India (RSSDI), and the Uttar Pradesh Council of Science and Technology (UPCST). Dr. Khattri has published extensively in peer-reviewed journals and has supervised numerous MD and PhD scholars.

Member of the Headache and Sensory Disorders Branch, Chongqing Stroke Society Member of Chongqing Health Promotion Association Vertigo Specialist Committee Member of the High-Risk Population Management Branch for Cerebrovascular Diseases, Chongqing Stroke Society Council Member of Chongqing Geriatrics Alliance Board of Directors Specialty: Possesses extensive clinical experience in the diagnosis and treatment of headache, vertigo, cerebral infarction, and epilepsy. Proficient in nerve block therapy for headache management.

Erna Kristin is Professor of Pharmacology and Therapy at the Department of Pharmacology and Therapy, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada. Her career spans over three decades with a solid foundation in pharmaceutical sciences, Professor Kristin obtained her Bachelor's, Master's, and Doctoral degrees from Universitas Gadjah Mada, demonstrating her deep-rooted connection to the institution. She was trained as a pharmacist and her main research area is pharmacoepidemiology, pharmacoeconomic, pharmacovigilance, pharmacogenomic, clinical pharmacology, and health technology assessment. Her research portfolio is extensive, with numerous publications in high-impact journals, focusing on drug efficacy & safety, health outcomes, and the optimization of therapeutic strategies. These works have not only enriched academic literature but have also influenced clinical practices and health policies. She has collaborated with health professionals and policymakers in various institutions to help implement drug formulary at the national level and hospital level. She has experience in conducting economic evaluations and analyses using real-world data to support the National Health Insurance program in Indonesia. Professor Kristin is a dedicated educator. She has mentored countless students, guiding them through their academic journeys and instilling in them a passion for research and lifelong learning. Her expertise has led to her participation in various committees at the national level in Indonesia. She is the vice chairman of the National List of Essential Medicine Committee, vice chairman of the National Committee on Drug Formulary, a member of the National Committee on Health Technology Assessment, and a member of the National Committee on Drug Evaluation at The National Agency of Drug and Food Control.

Dr. Vikas Kumar, MD, DM (Clinical Pharmacology), is an Assistant Professor in the Department of Pharmacology at AIIMS Bathinda, India. His expertise spans clinical pharmacology, drug discovery and development, clinical trials, research methodologies, biostatistics, and bioanalytical techniques including HPLC. He previously served as Lead Medical Operations, Clinical Development (Biologics) at Dr. Reddy’s Lab, Hyderabad, and as Senior Resident at AIIMS Rishikesh. Dr. Kumar holds a DM in Clinical Pharmacology from AIIMS Rishikesh, an MD in Pharmacology from Government Medical College, Amritsar, and an MBBS from Tribhuvan University, Kathmandu. He has over 50 publications in national and international peer-reviewed journals, has received multiple research awards and grants, and holds a patent for an antibacterial and antifungal formulation using grape seed and pomegranate peel extracts.

Gwyneth is a fourth-year undergraduate student from the University of Sydney with a passion for promoting student research. She is interested in pharmacoepidemiology, personalised medicine and healthcare access. Currently, she serves as a copy editor for the Australian Pharmacy Student's Journal, the only peer-reviewed pharmacy student journal in the world.

M.D., Ph.D. Svjetlana Loga-Zec was born in Sarajevo on January 21. She graduated from the Faculty of Medicine, University of Sarajevo, where she also completed postgraduate studies in experimental medicine. She is a specialist in clinical pharmacology. Since 1993, she has been employed at the Faculty of Medicine, University of Sarajevo, where she is currently a Full Professor and Head of the Department of Pharmacology, Toxicology and Clinical Pharmacology. She is actively involved in undergraduate and postgraduate teaching.Prof. Loga-Zec has been actively involved in international scientific collaboration and research initiatives and has been a member of the European Association of Clinical Pharmacologists since 2000.

Ran Yan, female, graduated with a full-time bachelor's degree from Chongqing Medical University. She serves as a member of the Chongqing Digital and Intelligent Nursing Professional Committee and the secretary of the Pengshui Miao and Tujia Autonomous County Nursing Quality Control Center. With extensive experience in various positions including general surgery, oncology, nursing department, and infectious diseases, she has accumulated profound clinical nursing and management expertise. She has been repeatedly honored as an advanced individual within the hospital and an outstanding nursing worker at the county level.

Fourth-year pharmacology resident with a particular academic interest in pharmacogenetics, which constitutes the focus of my MD thesis.

Jorge Enrique Machado Alba, MD, PhD in Pharmacology and Master in Pharmacoepidemiology, Director of the Pharmacoepidemiology and Pharmacovigilance Research Group (Category A1 of Minciencias), professor of pharmacology and toxicology in the Medicine program of the Faculty of Health Sciences at the Universidad Tecnologica de Pereira for more than 30 years, and leader of the research area. He has extensive academic and research experience, especially in drug utilization studies in the Colombian population.

Jorge Enrique Machado Alba, MD, PhD in Pharmacology and Master in Pharmacoepidemiology, Director of the Pharmacoepidemiology and Pharmacovigilance Research Group (Category A1 of Minciencias), professor of pharmacology and toxicology in the Medicine program of the Faculty of Health Sciences at the Universidad Tecnologica de Pereira for more than 30 years, and leader of the research area. He has extensive academic and research experience, especially in drug utilization studies in the Colombian population.

Jorge Enrique Machado Alba, MD, PhD in Pharmacology and Master in Pharmacoepidemiology, Director of the Pharmacoepidemiology and Pharmacovigilance Research Group (Category A1 of Minciencias), professor of pharmacology and toxicology in the Medicine program of the Faculty of Health Sciences at the Universidad Tecnologica de Pereira for more than 30 years, and leader of the research area. He has extensive academic and research experience, especially in drug utilization studies in the Colombian population.

Master of Neurology graduate. Graduated from Chongqing Medical University with a degree in Neurology in 2017 and has been engaged in clinical practice in neurology for many years. Specializes in the diagnosis and treatment of common and frequently encountered neurological disorders, including cerebrovascular diseases, dizziness and vertigo, Parkinson's disease, migraine, epilepsy, and sleep disorders. Particularly has conducted in-depth research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

I am currently serving as an Associate Professor in the Department of Microbiology, Faculty of Medicine, Manipal University College Malaysia. My area of research focuses on Infectious Diseases, with particular emphasis on antimicrobial resistance and novel anti-infective strategies. My doctoral research examined the bactericidal potential of lysostaphin against methicillin-resistant Staphylococcus aureus (MRSA), contributing to insights into bacterial decolonization and wound healing. I have also worked extensively on the epidemiological typing of MRSA and multidrug-resistant Gram-negative bacteria from clinical samples. More recently, my research has expanded to bacteriophage-derived proteins as alternative therapeutic agents against Staphylococcus aureus. I am a recipient of the Summer Research Fellowship and the Visiting Scientist Fellowship from the Indian Academy of Sciences. In addition, I actively contribute to the scientific community as a peer reviewer for Scientific Reports, BMC Infectious Diseases, and BMC Public Health, and editor for Reviews and Research in Medical Microbiology and Bradley Journal.

Dr. Eunice Pak (MBBCh, AFHEA) is a specialised foundation programme resident doctor currently working at West Suffolk Hospital in the UK. She graduated from Cardiff University in July 2025 and aspires to pursue a career as a clinical academic. Throughout her medical school years, she was heavily involved in research projects and presented her work at national and international conferences, primarily in the areas of clinical pharmacology and paediatrics. Later in the year, Dr. Pak will undertake a four-month academic block at the University of Cambridge during her Foundation Year 2 training, focusing on medical oncology. She enjoys teaching, exploring new medical innovations, and engaging with medical humanities, including how medicine is applied in the fields of art, music, literature, and history. In her spare time, she enjoys hiking, watching tennis, singing, listening to music, playing board games, and maintaining her blogs. She is presenting two posters at the WCP: one titled “Is there a Difference in Odds Ratio between Quinolone Antibiotics and Associated Neuropsychiatric Adverse Events?”, which was a summer studentship project completed in 2024 and funded by the Wellcome Trust/Academy of Medical Sciences, and another innovative medical education project conducted in collaboration with professors from her university.

Dr. Amber is an Assistant Professor in the Department of Biological and Biomedical Sciences at Aga Khan University. She holds a PhD in Health Sciences with a specialization in immunopharmacology. Her research lies at the intersection of natural product pharmacology, risk stratification, and health sciences, with a strong focus on the prevention of non-communicable diseases (NCDs), including cardiovascular disease (CVD), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). Her work centers on developing predictive models for early disease risk assessment while investigating the therapeutic potential of natural compounds in modulating inflammation and metabolic health. By integrating epidemiology, precision medicine, and pharmacoepidemiology, she aims to refine risk assessment tools and translate research findings into effective, evidence-based prevention strategies. In addition to her research, Dr. Amber has actively contributed to curriculum modification and integration within the medical and biomedical sciences programs, aligning basic sciences with clinical application and contemporary health priorities. She is a recipient of awards for innovative teaching and early-career excellence, reflecting her commitment to educational advancement and learner-centered pedagogy.

Dongyoung Park is a clinical pharmacist and Integrated Masters and PhD program at the College of Pharmacy, The Catholic University of Korea. His academic interests center on clinical pharmacy and trustworthy medical artificial intelligence, with a focus on pharmacoepidemiology, real-world evidence, and clinical decision support. He has conducted population-based studies using national health insurance and hospital electronic health record data, applying machine learning, graph neural networks, and causal inference methods to drug safety, dosing optimization, and adverse event prediction. His recent work explores reinforcement learning–based policy learning for erythropoiesis-stimulating agent dosing and the integration of explainable AI models into real-world clinical workflows.

Sangmin Park, PharmD, is a U.S.-licensed pharmacist and a researcher in the Clinical Pharmacy Laboratory at the College of Pharmacy, The Catholic University of Korea, where he is pursuing an integrated master’s and PhD program. His research focuses on real-world evidence and pharmacoepidemiology, with particular interest in medication safety and adverse drug reactions, including opioid-related safety and drug-induced QT prolongation, as well as the optimisation of pharmacotherapy in complex patient populations. At WCP 2026, he will present a nationwide claims-based analysis using the Korea Health Insurance Review and Assessment Service (HIRA) database (2011–2021) examining trends in maintenance immunosuppressive regimens among liver transplant recipients in Korea.

Damir Erceg is an Associate Professor of Pharmacology at the School of Medicine and Faculty of Health Studies, Catholic University of Croatia, Zagreb, Faculty of Dental Medicine and Health, School of Medicine, “Josip Juraj Strossmayer” University of Osijek. He is a physician and clinical pharmacologist at Srebrnjak Children's Hospital in Zagreb. He has 10 years of experience in basic, clinical pharmacology, and pharmacovigilance in the pharma industry. He was one of the founders and the first Director of the Croatian Antidoping Agency. Drug safety, drug interactions, drug allergy, anti-inflammatory drugs, personalized medicine, and anti-doping are his main professional interests. He has twenty years of experience in pediatric clinical trials.

Marian Klose is a PhD student at the Chair of Pharmacology and Toxicology at Witten/Herdecke University, Germany. Building on a background in Microbiology (M.Sc. from the University of Bonn), his current research addresses the antimicrobial resistance crisis through drug repurposing. Specifically, he investigates the antibacterial potential of farnesyltransferase inhibitors, originally developed for cancer therapy. The primary focus lies on elucidating their mechanism of action and evaluating efficacy against resistant pathogens. By exploring these repurposed compounds, he aims to identify novel therapeutic strategies and contribute to the development of new antibiotic classes to improve patient outcomes.

Professor Dr Koh Kwee Choy (James) is the Professor of Internal Medicine and the Deputy Dean for Clinical Sciences, Development and Community Engagement at the School of Medicine, IMU University, Malaysia. He holds an MBBS and MMed (Medicine) and is a Fellow of the Royal College of Physicians and the Academy of Medicine, Malaysia. An infectious diseases specialist with extensive expertise in HIV medicine, he played a significant leadership role in Malaysia’s COVID-19 response, contributing to clinical strategy, frontline management, and multidisciplinary coordination during the pandemic. He serves on the Malaysian Medical Council Subcommittee for Infectious Diseases and contributes to the International AIDS Society. His work reflects sustained commitment to clinical excellence, academic leadership, and medical education.

Dr. Liang Chunsu focuses on new methods of pharmaceutical analysis and clinical pharmacy research. She currently serves as Member of the Pharmaceutical Analysis Technology Branch of China Association for Biomedical Technology and Member of the Pharmaceutical Research and Clinical Evaluation Committee of China Medical Education Association. She has presided over projects like the National Natural Science Foundation of China and Peking Union Medical College Talent Support Program. Having published 16 SCI journal papers and over 20 Chinese papers, she has given oral presentations at international and domestic conferences such as ACCP, gaining certain academic influence in related fields.

Nisa maria (University of Sydney, Australia) is a second-year PhD student at Sydney Pharmacy School, University of Sydney. Her research focuses on optimizing safety monitoring for a new shorter 6-month BPaL(M) regimen for MDR/RR-TB. In the first year of her PhD study, she published a systematic review of adverse events associated with a new regimen for DR-TB that presented comprehensive data from clinical trials, implementation, and pharmacovigilance studies. Subsequently, she completed a project to develop a modified trigger tool to identify ADRs during treatment in patients with MDR/RR-TB. Prior to her PhD, Nisa served as a lecturer and researcher at Universitas Indonesia, where she coordinated the Drug Information Centre and member of the Academic Health System (AHS) TB Task Force. She also has experience as a clinical pharmacist in a hospital and has worked in the pharmaceutical industry as a clinical trial officer and as a local person for pharmacovigilance.

Dr. Emanuel F. Matias is a resident physician in Infectious Diseases at the University Hospital Center of São João, and an invited teaching assistant in Basic & Clinical Pharmacology, Therapeutics, and Infectious Diseases at the Faculty of Medicine of the University of Porto, Portugal. Holding an MD (2019) and a Diploma in Tropical Medicine & Hygiene (2025), he is currently a PhD candidate in Clinical & Experimental Pharmacology and Toxicology. His research focuses on the interplay between infection, inflammation, and endocannabinoid signaling. Besides interest in medical sciences, he also completed a Postgraduate Diploma in Sacred Music (2019).

Yun-Gyeong Lee is a postdoctoral researcher in the Department of Pharmacology at Chonnam National University Medical School, South Korea. Her research focused on the role of Ret finger protein (RFP/TRIM27) in adipose tissue and systemic metabolic regulation. She is particularly interested in how RFP modulates PPAR-γ–dependent adipogenesis and contributes to diet-induced obesity and insulin resistance. Her recent work demonstrated that genetic ablation of RFP attenuates adipogenesis and protects male mice from high fat diet-induced obesity and metabolic dysfunction.

Sohyeon Lim is an integrated MS–PhD student in the Department of Clinical Pharmacology and Therapeutics at Seoul National University College of Medicine and Seoul National University Bundang Hospital, Republic of Korea. Her research interests lie in clinical pharmacology and pharmacometrics, particularly population pharmacokinetic modeling for model-informed drug dosing. She has experience in nonlinear mixed-effects modeling and pharmacokinetic analyses using NONMEM, R, Python, and Phoenix WinNonlin.

The presenting author is a Medical Doctor (M.D.), Ph.D., Professor at Shanghai University of Sport, a Licensed Pharmacist, and an Exercise Prescription Specialist. With a long-standing focus on exercise-based prevention and treatment of chronic diseases, the author and her team pioneered the "Chronic Disease Exercise Clinic," developed an AI-driven management system for chronic disease exercise interventions, and established a volunteer service team for diabetes exercise and health. The presenting author has authored or co-authored over 80 research papers and served as editor-in-chief or contributing author for six books. Her professional roles include Vice Chair of the Chinese Society of Reproductive Pharmacology, Expert Committee Member of the Shanghai Expert Committee for Exercise Promoting Health, Standing Committee Member of the Evidence-Based Committee of the Chinese Association of Rehabilitation Medicine, and Deputy Head of the Community-Exercise for Health Promotion Group of the Chinese Association of Rehabilitation Medicine, among others.

Prof Madiba (Mothibe) is affiliated with Rhodes University (RU), Faculty of Pharmacy, and is the HOD of the Pharmacology Division. A registered Medical Biological Scientist with the Health Professions Council of SA (HPCSA), and the president (2025-2027) of the South African Society for Basic and Clinical Pharmacology (SASBCP). Her research focus is on the pharmacology and toxicology of medicinal plants, particularly those used as African traditional medicine (ATM); and she firmly believes that traditional medicine plays a notable role in public health. She believes that the greatest achievement of research in ATM would be institutionalisation of African Traditional Medicine for better health care provision. Her contribution in that regard includes her serving as a member of the Working Group of Experts for the national regulatory authority for health products, SAHPRA, for the development of a regulatory framework for the commercialisation of African traditional proprietary medicines. She continues serving as a supervisor to postgraduate students, a peer-reviewer for numerous journals and as an ethics reviewer for the Human Research Ethics Committee in her institution. She actively engages in discourses on the role of ATMs at various platforms, advancing and providing guidance on evidence-based and science-based knowledge on the medicines. She has more than two decades of experience teaching basic and clinical pharmacology; including clinical toxicology, complementary, alternative and traditional medicines; at undergraduate and postgraduate levels to health science students, and is passionate about pharmacology education and the decolonisation of its curriculum.

Dr. Arpita Maitra, MBBS, MD (Pharmacology), is an Associate Professor in the Department of Pharmacology at Burdwan Medical College, West Bengal, India. She completed her MBBS from Calcutta National Medical College in 2008 and earned her MD in Pharmacology from Burdwan Medical College in 2014, where she was the university topper under WBUHS. Dr. Maitra began her academic career as a Postgraduate Trainee in Pharmacology (2014–2017) and subsequently served as Demonstrator at RG Kar Medical College, Kolkata, before joining Burdwan Medical College as Assistant Professor in 2018 and later as Associate Professor in 2024. She has published eight articles in national and international indexed journals and presented research at multiple national conferences, including posters at the World Congress of Pharmacology 2023 in Glasgow. She serves as Coordinator of the Pharmacovigilance Committee at AMC, Burdwan Medical College, and has acted as internal and external examiner in MBBS examinations across various medical colleges, contributing significantly to medical education and research.

Dr. Pramod Kumar Manjhi, MBBS, MD (Pharmacology), NTTC (JIPMER), BCBR (ICMR-NIE), is Additional Professor and Head of the Department of Pharmacology at the All India Institute of Medical Sciences (AIIMS), Patna, Bihar, India. His research and professional interests span basic, clinical, and experimental pharmacology, clinical trials, research methodology, pharmacovigilance and materiovigilance, rational use of drugs, patient safety, pharmacogenomics, precision medicine, and medical education. Dr. Manjhi serves as Lead Trainer and Nodal Officer for Mission Karmayogi at AIIMS Patna and holds key academic leadership roles including Faculty In-charge of the Recruitment Cell, Sub Dean (UG Academics), and Coordinator for AMC & MDMC programs and the 2nd Professional MBBS curriculum. He is also Member Secretary of the Institute Animal Ethics Committee and a member of the Hospital Infection Control Committee and Drug & Therapeutic Committee at AIIMS Patna. Nationally, he is an Executive Council Member of the National Association of Pharmacology & Therapeutics and a life member of multiple professional bodies including NAPT, IPS, ISRPT, IMA, SOPI, SASPI, ISCR, and ASPIGIMS. He is Editor-in-Chief of IJCRR and Associate Editor of TRIALS, with 37 research publications in peer-reviewed journals.

Shokhmurod Molaikhanov is a Clinical Pharmacologist, Lecturer in Pharmacology, and Healthcare Administrator based in Almaty, Kazakhstan. He serves as Assistant Lecturer in the Department of Pharmacology at Asfendiyarov Kazakh National Medical University (KazNMU) and works as a Physician–Clinical Pharmacologist. He is a member of both the Professional Association of Clinical Pharmacologists and Pharmacists (Kazakhstan) and the European Association of Clinical Pharmacologists and Therapeutics (EACPT). Dr. Molaikhanov holds a Master’s Degree in Healthcare Management from Al-Farabi Kazakh National University and completed his residency in Clinical Pharmacology, internship in Surgery, and MD in General Medicine at KazNMU. He has five years of professional experience, teaching pharmacology to undergraduate and postgraduate students, delivering lectures and practical classes in clinical pharmacology, and contributing to clinical decision support, rational pharmacotherapy, and medication safety. He has participated in the development and expert review of national clinical protocols, contributed to academic mobility initiatives, and delivered lectures internationally, including as a Visiting Lecturer at Bukhara State Medical Institute, Uzbekistan. His achievements include the “Best National Speaker” Award (2017), multiple state and institutional medals, and recognition for developing national pharmacology assessments and clinical protocols.

Professor Muscoli leads a multidisciplinary research team committed to the development and preclinical evaluation of innovative analgesic compounds with improved efficacy and safety profiles. Her work places particular emphasis on receptor pharmacology, biomarker discovery, and personalized approaches to pain management. By integrating pharmacology, neuroscience, and translational medicine, she investigates novel therapeutic targets and signaling pathways involved in nociception and neuroimmune interactions. Through collaborations with clinical and industrial partners, she aims to bridge the gap between laboratory findings and patient care. She has authored numerous peer-reviewed publications and regularly presents her findings at international conferences. In addition to her research activities, she is deeply committed to teaching and mentoring students in pharmacology and biomedical sciences.

Professor Muscoli leads a multidisciplinary research team committed to the development and preclinical evaluation of innovative analgesic compounds with improved efficacy and safety profiles. Her work places particular emphasis on receptor pharmacology, biomarker discovery, and personalized approaches to pain management. By integrating pharmacology, neuroscience, and translational medicine, she investigates novel therapeutic targets and signaling pathways involved in nociception and neuroimmune interactions. Through collaborations with clinical partners, she aims to bridge the gap between laboratory findings and patient care. She has authored numerous peer-reviewed publications and regularly presents her findings at international conferences. In addition to her research activities, she is deeply committed to teaching and mentoring students in pharmacology and biomedical sciences.

Se Hoon Oh is a pharmacist and graduate student at the College of Pharmacy, The Catholic University of Korea. His academic interests focus on clinical pharmacy and pharmacoepidemiology, with particular emphasis on opioid and analgesic utilization, drug safety, and real-world evidence analysis. He has conducted population-based studies using national health insurance claims data to examine long-term prescribing trends and associated comorbidities. His recent work explores international comparisons of tramadol use and highlights regulatory and clinical challenges in pain management.

Momoka Okamura is a fifth-year undergraduate pharmacy student in the School of Pharmaceutical Sciences at the University of Shizuoka, Japan, where she is affiliated with the laboratory of Pharmacy Practice and Sciences (Professor Shinya Uchidaʼs laboratory). She will graduate and obtain her pharmacist license in 2027. Her research project focuses on clinical pharmaceutics, particularly the development and evaluation of foam-based formulations. She aims to contribute to improving patient usability and medication accessibility through patient-centered formulation design. She is also involved in developing oral foam formulations for patients with dysphagia.

Dr. Amber is an Assistant Professor in the Department of Biological and Biomedical Sciences at Aga Khan University. She holds a PhD in Health Sciences with a specialization in immunopharmacology. Her research lies at the intersection of natural product pharmacology, risk stratification, and health sciences, with a strong focus on the prevention of non-communicable diseases (NCDs), including cardiovascular disease (CVD), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). Her work centers on developing predictive models for early disease risk assessment while investigating the therapeutic potential of natural compounds in modulating inflammation and metabolic health. By integrating epidemiology, precision medicine, and pharmacoepidemiology, she aims to refine risk assessment tools and translate research findings into effective, evidence-based prevention strategies. In addition to her research, Dr. Amber has actively contributed to curriculum modification and integration within the medical and biomedical sciences programs, aligning basic sciences with clinical application and contemporary health priorities. She is a recipient of awards for innovative teaching and early-career excellence, reflecting her commitment to educational advancement and learner-centered pedagogy.

As a Master of Pharmacy student at Monash University and an Intern Pharmacist at HealthSmart Pharmacy (VCCC), Yujoung Joung focuses on the safe and quality use of medicines in everyday practice, including dispensing, compounding, and patient counselling. Her academic work has explored deprescribing and medication-related decision-making in dementia, shaping her interest in evidence-based medication use and patient-centred care. She is the Founder and President of the Korean-Australasian Pharma Association (KAPA), where she leads mentoring and education initiatives for students and early-career professionals.

Dr. Niveditha K, MBBS, MD, DM, completed super-specialty training from premier central institutes of India, including JIPMER and PGI. Within a year of completing her DM, she has actively engaged in advancing Model-Informed Precision Dosing (MIPD) in clinical practice. My primary focus areas include oncology pharmacokinetics and exposure-guided chemotherapy optimization. She is particularly interested in integrating Bayesian forecasting and therapeutic drug monitoring into routine oncology care to support individualized, evidence-based treatment strategies.

Dr. C. M. Kamaal, MBBS, DCH, MD (Pharmacology) is a Professor of Pharmacology & Therapeutics at SMMH Government Medical College, Saharanpur, India, with dual specialization in Pediatrics and Pharmacology. With over two decades of clinical experience and more than 16 years in academic pharmacology, his work bridges clinical practice, rational therapeutics, and medical education. He is the Founder and National Coordinator of the National Association of Pharmacology and Therapeutics (NPT), a pan-India professional body dedicated to advancing academic, clinical, and research excellence in pharmacology. Dr. Kamaal is also Associate Editor of the National Journal of Pharmacology and Therapeutics and a certified assessor of the National Medical Commission (India). His academic interests include clinical pharmacology, pediatric therapeutics, competency-based medical education, pharmacovigilance, ethics, and good clinical practice. He actively contributes to national and international academic forums, promoting ethical and evidence-based use of medicines.

Noha Kamel is a PhD candidate at the University of Sydney’s School of Pharmacy, investigating clinical practices and gaps in care for gout patients undergoing dialysis. Her work includes a published scoping review and a retrospective chart review on allopurinol dosing and serum urate concentrations in this population.

Dr. Mert Kaşkal is a medical pharmacologist and academic affiliated with the Department of Medical Pharmacology at Marmara University, Istanbul, and an honorary research associate at the Liverpool Centre for Cardiovascular Sciences (University of Liverpool). His current research interests include pharmacoepidemiology, cardiopulmonary diseases, and optimizing drug safety and effectiveness, with a particular focus on special populations and teratology. He has published his work in international peer-reviewed journals and has presented at international congresses through oral and poster presentations.

Jani Katajapuhjo, MD, MScPharm, is a PhD student at the University of Helsinki and a physician specializing in clinical pharmacology at HUS Helsinki University Hospital. He earned his medical degree in 2025 and MScPharm degree in 2021, both from the University of Helsinki, Finland. His key research interests include both clinical and pre-clinical study of drug metabolism. His doctoral research focuses on drug–drug interactions and the validation of novel endogenous biomarkers for CYP enzyme phenotyping.

Dr Aili Langford is a pharmacist, Lecturer and National Health and Medical Research Council (NHRMRC) Emerging Leader Research Fellow at the Sydney Pharmacy School. Dr Langford’s research focuses on reducing medication-related harm through deprescribing.

Dr. Lin Yang，a Chief Pharmacist, Professor and doctoral supervisor. She specializes in new drug research, clinical pharmacology, pharmacy administration and pharmaceutical education. She currently serves as Chief Pharmacist of Beijing Hospital Management Center, Director of Pharmacy Department at Beijing Anzhen Hospital, Capital Medical University, Director of Research Ward, and Head of Clinical Trial Center (Phase I Unit). She is also Deputy Director of the Department of Clinical Research and Epidemiology, Capital Medical University. As the project leader, she has undertaken numerous national and provincial-level projects, including the "Construction of a Clinical Research Demonstration Platform for Cardiovascular Disease Drugs" under the Major New Drug Development Program, the "Precision Medicine Research Key Special Project: Precision Research on Diagnosis and Treatment Protocols for Coronary Heart Disease and Atrial Fibrillation". As a PI of Phase I Unit, she has led over 100 Phase I-II clinical trials.

Dr. Suzana Mustafa is a Clinical Pharmacist at Hospital Raja Perempuan Zainab II, Kelantan, Ministry of Health, Malaysia, with more than 20 years of experience in hospital pharmacy practice, clinical pharmacy services, and therapeutic drug monitoring (TDM). She obtained her PhD in Pharmacology in 2017, with research interests focusing on pharmacokinetics–pharmacodynamics (PK/PD), population pharmacokinetics, and precision medicine. Dr. Suzana has authored over 20 scientific publications and remains actively involved in advancing evidence-based pharmacotherapy and individualized patient care.

Ms Ngcobo holds a Bachelor of Pharmacy (BPharm) degree from Rhodes University and a Master of Pharmacy (Pharmacology) from the University of KwaZulu-Natal (UKZN). She also holds a certificate in Quality Assurance in the Pharmaceutical Manufacturing Industry from North-West University. She is currently a PhD candidate in Pharmacology at UKZN, where her research investigates the effectiveness of rituximab in rare inflammatory conditions, with a focus on improving therapeutic outcomes in immunological diseases. Ms Ngcobo joined UKZN as a Lecturer in Pharmacology in 2024 and is actively involved in teaching undergraduate pharmacology courses. She completed her pharmacy internship at King Edward VIII Hospital in Durban and subsequently served at Nkonjeni Hospital in Ulundi, gaining valuable clinical experience in patient care within resource-limited settings. Her academic training, clinical background, and research interests reflect a strong commitment to advancing pharmacological research and education, particularly in the area of inflammatory and immune-mediated disorders.

Dr. Shusuke Ozawa is the Chief pharmacist at the Department of Pharmacy, Shinshu University Hospital, Japan. He received his Ph.D. in Medicine from Shinshu University in 2021. His research focuses on perinatal clinical pharmacology, investigating the placental and lactational transfer of psychotropic medications. His work aims to provide safety data for medication use during pregnancy and breastfeeding.

Clinical Pharmacy PhD, Master's Supervisor Deputy Director, Clinical Pharmacy Subspecialty, Zhongshan Hospital, Fudan University Head of Pharmacy Department, Zhongshan Hospital (Xiamen), Fudan University Shanghai "New Star of Medicine" Young Medical Talent; Young Talent of the Chinese Pharmaceutical Association; Young Talent of the Shanghai Pharmaceutical Association Scholar of the Harvard Global Clinical Scholars Research Training Program First/Corresponding author of 14 SCI papers and 10 core Chinese journal papers Principal investigator of 12 research projects, including grants from the National Natural Science Foundation of China etc. Standing Committee Member and Secretary of the Youth Committee, Therapeutic Drug Monitoring Research Committee, Chinese Pharmacological Society; Youth Committee Member, Drug-induced Diseases Committee, Shanghai Pharmaceutical Association Recipient of honors including the Top Ten "2022 Patient Safety Goal Practice Typical Cases" by the Chinese Hospital Association for pharmaceutical care case; the 2021 "Pharmacy Elite" Award by the Clinical Pharmacy Branch of Shanghai Medical Association.

Deputy Director Pharmacist of the Pharmacy Department, General Hospital of Ningxia Medical University PhD in Medicine, Master's Supervisor Clinical Pharmacist specializing in ICU Young Member of the Professional Committee on Drug-Induced Diseases, Chinese Pharmacological Society Member of the High-Alert Medications Professional Committee, China Medical Education Association Member of the Medical Insurance Management Professional Committee, Ningxia Pharmaceutical Association Young Editorial Board Member of Modern Drugs and Clinical Practice Journal Young Backbone Talent in Medicine, Ningxia Medical University Research Directions: Individualized Drug Therapy / Novel Drug Delivery Systems

Dr. Farhan Ahmad Khan is a distinguished clinical pharmacologist and researcher with over 16 years of experience in teaching, research, and professional service. He is a Professor in the Department of Pharmacology at J.N. Medical College, Aligarh Muslim University, where he has played a pivotal role in advancing clinical pharmacology, pharmacovigilance, and rational use of medicines. Dr. Khan has served as Consultant to the Drug & Poison Information Centre and has coordinated the Adverse Drug Reaction Monitoring Centre under the Pharmacovigilance Programme of India. His research interests include pharmacovigilance, pharmacogenetics, antimicrobial resistance, and safe prescribing practices. An active contributor to global academia, he is the Chief Editor of the International Archives of Biomedical and Clinical Research. He is a Fellow of the British Pharmacological Society and the Faculty of Pharmaceutical Medicine (RCP, UK), and currently serves as an Elected Trustee of the British Pharmacological Society.

Amandeep Kaur is a PhD Scholar specializing in genetics and molecular biology, with a focus on advanced genotyping methods and disease-associated genetic variations. She is currently pursuing her doctoral research in the Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. She has previously worked as a Research Fellow in a Phase II clinical trial involving tuberculosis (TB) patients, contributing to clinical data management, patient follow-up, and study coordination. She has also participated in antimicrobial surveillance projects and has hands-on experience in pharmacokinetic (PK) studies, including sample processing and data interpretation. Her technical expertise spans PCR-based assays, gel electrophoresis, ELISA, DNA isolation, and other molecular biology techniques. She is also skilled in handling High-Performance Liquid Chromatography (HPLC) and has experience in drug standardization and analytical method development. She has presented her research at several academic platforms, including the European Society of Cardiology (ESC) Congress 2025 in Madrid. She remains committed to advancing molecular diagnostics, analytical pharmacology, and translational biomedical research. Beyond research, she is passionate about scientific writing and knowledge dissemination within the biomedical community.

Dhrita Khatri is a pharmacist, researcher, and PhD candidate at the Murdoch Children's Research Institute (MCRI) within the Cancer Therapies Group. With a clinical background spanning across Australia and New Zealand, Dhrita’s doctoral research focuses on developing and evaluating evidence-based educational interventions to integrate pharmacogenomics into routine clinical care. Using a design-based research approach, she aims to empower healthcare professionals across Australia to improve medication safety and efficacy. Through collaborations with the Royal Children’s Hospital, the University of Melbourne, and the Cancer CoLab, Dhrita’s work is deeply translational, focusing on enhancing precision medicine for vulnerable populations, including children with cancer.

I am a physician and clinical pharmacologist at Seoul National University College of Medicine and Seoul National University Hospital. I am currently pursuing an integrated M.S.–Ph.D. program in Clinical Pharmacology and Therapeutics (2022–2026), after receiving my MD from Seoul National University (2014–2020) and completing internship training at Seoul National University Hospital (2020–2021). My primary research interest is pharmacometrics, with a focus on pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation to support model-informed drug development. I have applied population PK/PD modeling and clinical trial simulation for dose selection and optimization across multiple Phase 1 studies, including AS-S603, AJH-2947, RCI001 eye drops, and DWP16001 in special populations. I am experienced in NONMEM and Monolix for PK/PD analyses, and Simcyp for physiologically based pharmacokinetic (PBPK) modeling. My work spans protocol development, trial operations under GCP, and integrated analysis of safety, PK, and PD data.

Dr. Huidi Liu, Associate Professor, Deputy Director of Heilongjiang Provincial Key Laboratory of Gut Microbiota and Pharmacogenomics. PhD in Microbial & Biochemical Pharmacy, postdoctoral fellow in Biology, and visiting scholar (Canada). Research focuses on natural antitumor pharmacology and gut microbiota. Author of 28 SCI papers (18 first/corresponding), 7 patent applications (2 granted). Editorial board member of Chinese Herbal Medicine; reviewer for J Ethnopharmacol, Front Pharmacol. PI of 11 national/provincial grants. Supervisor of 13 student innovation projects with 30+ awards.

Dr Stefanie Lip is a Clinical Senior Lecturer at the University of Glasgow and an Honorary Consultant in General Internal Medicine & Clinical Pharmacology and Therapeutics at the Queen Elizabeth University Hospital (NHS Greater Glasgow & Clyde). Her research focuses on pharmacogenomics and hypertension.

Chief Pharmacist Hospital Pharmacy High altitude PK/PD

I am a Research Officer at the Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, with expertise in pharmacogenetics and molecular medicine. My research focuses on how genetic variability in drug-metabolizing enzymes and transporters contributes to interindividual differences in drug response among Malaysian populations. I have led and contributed to institutionally and nationally funded projects involving pharmacogenomics, drug metabolism, and population-based genetic studies. My work includes developing cost-effective PCR-based genotyping methods and analysing genotype and allele frequency data to support clinical pharmacology research. Through this research, I aim to generate population-specific pharmacogenetic evidence to inform future pharmacokinetic and pharmacodynamic studies and support the integration of precision medicine into clinical practice in Malaysia.

Dr Julia Netylko completed her medical degree at Moscow State University, followed by residency in cardiology. She joined the Cancer Therapies group at the Murdoch Children’s Research Institute in October 2024. Her research focuses on pharmacogenomics in paediatric oncology, with current projects investigating genetic predisposition to anthracycline-induced cardiotoxicity and genotype-informed dosing of tacrolimus in solid organ transplant recipients. Julia is passionate about advancing personalised medicine approaches to improve treatment safety and outcomes for children.

Jonathan T. Nguyen is a graduate student working under the supervision of Drs. Ute Schwarz and Bradley Urquhart in the Department of Physiology and Pharmacology at Western University, London, Canada. His project focuses on the organic anion-transporting polypeptide family of drug transporters, specifically examining how they regulate metabolism by mediating bile acid transport in certain tissues. To investigate this topic, his research employs a range of methods, including metabolic mouse model testing, metabolomics, and transcriptomics.

Rashmi Kumari is an Assistant Professor in Hospital Administration at A. J. Institute of Hospital Management, A. J. Hospital and Research Centre, Mangalore, India. She has demonstrated a strong commitment to advancing research and education in healthcare management. Her scholarly contributions include four Scopus-indexed Q1/Q2 research publications, reflecting her focus on improving hospital operations, patient care, and administrative efficiency. She has actively participated in and presented at several reputed national and international conferences and workshops, enhancing her expertise and fostering knowledge exchange in the field of hospital administration. Rashmi’s work emphasizes the integration of innovative management practices with evidence-based healthcare solutions, contributing to the professional development of students and practitioners alike. Her dedication to research and academic excellence positions her as a promising contributor to contemporary discussions in healthcare management, with a growing reputation for insightful, impactful, and high-quality scholarship.

Professor Dave Lewis is a prominent educator in the School of Biomedical Sciences at the University of Leeds, specializing in pharmacology, scientific ethics, and education for professional and sustainable development. He is recognized for implementing innovative,, authentic assessments and the 3Rs framework (Replacement, Reduction, Refinement) in animal research.

Dr Willmann Liang presently serves as Senior Lecturer in the Department of Pharmacology and Pharmacy at the University of Hong Kong (HKU). Dr Liang obtained his BSc(Hons) (in Pharmacology and Therapeutics) and PhD (in Cardiovascular Pharmacology) degrees from the University of British Columbia in Canada. He proceeded to receive a Postgraduate Diploma (in Higher Education) from the National Institute of Education in Singapore. Over the years, Dr Liang has published and received honours in the areas of pharmacology and biomedical sciences education. He also holds an adjunct position for developing and teaching a summer pharmacology course at Tunghai University in Taiwan. He was elected as a Chartered Biologist (CBiol) in 2014 and a Fellow of the Academy of Pharmacology Educators (FAPE) in 2021. Since 2024, he is also a Fellow of Advance HE (formerly Higher Education Academy) (FHEA) and a Mentor of the HKU Advance HE Fellowship Scheme.

Dr. Arpita Maitra, MBBS, MD (Pharmacology), is an Associate Professor in the Department of Pharmacology at Burdwan Medical College, West Bengal, India. She completed her MBBS from Calcutta National Medical College in 2008 and earned her MD in Pharmacology from Burdwan Medical College in 2014, where she was the university topper under WBUHS. Dr. Maitra began her academic career as a Postgraduate Trainee in Pharmacology (2014–2017) and subsequently served as Demonstrator at RG Kar Medical College, Kolkata, before joining Burdwan Medical College as Assistant Professor in 2018 and later as Associate Professor in 2024. She has published eight articles in national and international indexed journals and presented research at multiple national conferences, including posters at the World Congress of Pharmacology 2023 in Glasgow. She serves as Coordinator of the Pharmacovigilance Committee at AMC, Burdwan Medical College, and has acted as internal and external examiner in MBBS examinations across various medical colleges, contributing significantly to medical education and research.

Graham Mackay is a Pharmacology educator at the University of Melbourne. He teaches pharmacology broadly across a range of areas with specific pedagogical development interests in enhancing authentic, workplace relevant learning.

Professor Janet Mifsud de Gray PhD, is Head, Department of Clinical Pharmacology and Therapeutics, University of Malta. Her area of expertise is in the pharmacology of medicines used in chronic neurological disorders especially epilepsy, ethical and bioethical issues in health care, pharmacotoxicology, and education in pharmacology. She has published extensively in her area of expertise. She was a Fulbright Scholar and DAAD awardee. She is member of the IUPHAR Education Council and has been involved in several EU and internationally funded projects. She is Fellow of the British Pharmacological Society in 2017, former Vice-President (Europe) International Bureau for Epilepsy. and Ambassador for the International League Against Epilepsy.

Dr Paul J Mitchell is a Senior Lecturer/Associate Professor in the Dept of Life Sciences at the University of Bath, where he teaches experimental pharmacology at UG, PG and post-doctoral level with special focus on robust experimental design, data handling and rigorous statistical analysis. This resulted in a complete programme of study for students at Bath and the University of Galway, coupled to his textbook Experimental Design and Statistical Analysis for Pharmacology and the Biomedical Sciences (Wiley 2022). He joined the British Pharmacological Society (BPS) in 1980 and was a member of both the Expert Groups advising the BPS on the UG core curriculum (2016) and the core UG learning outcomes for the use of animals in research (2017). He is a member of the BPS Education and Training committee and is CEO/MD of Experides Ltd., providing guidance and education in experimental design and statistical analysis. Paul was appointed to Fellow of the BPS in November 2023, and Fellow of the Royal Society of Biology in April 2025.

Dr Miriam Moriarty, PhD, is a Lecturer in Pharmacology & Therapeutics at the University of Galway with over fourteen years’ experience teaching across undergraduate and postgraduate biomedical programmes. She holds a BSc, MSc (Neuropharmacology) and PhD in Molecular/Developmental Biology from the University of Galway, and an MSc in Bioprocessing from the University of Limerick. Her doctoral research investigated the role of plakophilin 2 in zebrafish heart development, contributing to understanding of cardiovascular development and disease. Dr Moriarty’s current work focuses on science education in pharmacology and biomedical science, integrating active learning, research-led teaching and biostatistics into curricula. She has experience in curriculum design, laboratory coordination, and research supervision, and has lectured in Molecular Biology at ATU Sligo. She also holds a Postgraduate Certificate in Teaching and Learning in Higher Education and a Postgraduate Diploma in Academic Practice.

Dr. Mraiche is an Associate Professor in the Department of Pharmacology, Faculty of Medicine & Dentistry at the University of Alberta and the Vargo Teaching Chair. She is committed to educational excellence, curriculum design, and innovative teaching in health sciences education, with a strong focus on enhancing student learning and program outcomes. With international academic experience across Canada and the Middle East, Dr. Mraiche brings a global perspective to teaching, academic leadership, and the scholarship of teaching and learning. She has played a key role in the development, implementation, and evaluation of competency-based undergraduate and graduate programs, and has contributed to educational innovation within diverse and cross-cultural learning environments. Her academic and administrative leadership continues to advance excellence in education.

Adeladlew Kassie Netere is a PhD candidate in Pharmacy Education at Monash University's Faculty of Pharmacy and Pharmaceutical Sciences. He has practical experience in pharmaceutical care and public health outcome research, along with teaching as a clinical pharmacist. Since 2022, he has been creating innovative resources for pharmacology education. His specialty is combining quantitative and qualitative methods to design and validate educational assessment tools. For his doctoral research, he developed, tested, and validated the Pharmacology Concept Inventory (PCI), a diagnostic tool to support concept-based pharmacology teaching.

Ms Ngcobo holds a Bachelor of Pharmacy (BPharm) degree from Rhodes University and a Master of Pharmacy (Pharmacology) from the University of KwaZulu-Natal (UKZN). She also holds a certificate in Quality Assurance in the Pharmaceutical Manufacturing Industry from North-West University. She is currently a PhD candidate in Pharmacology at UKZN, where her research investigates the effectiveness of rituximab in rare inflammatory conditions, with a focus on improving therapeutic outcomes in immunological diseases. Ms Ngcobo joined UKZN as a Lecturer in Pharmacology in 2024 and is actively involved in teaching undergraduate pharmacology courses. She completed her pharmacy internship at King Edward VIII Hospital in Durban and subsequently served at Nkonjeni Hospital in Ulundi, gaining valuable clinical experience in patient care within resource-limited settings. Her academic training, clinical background, and research interests reflect a strong commitment to advancing pharmacological research and education, particularly in the area of inflammatory and immune-mediated disorders.

Dr Suong Ngo has been a member of ASCEPT since 1999. Her current research focuses on the anti-cancer stem cell effects of cruciferous vegetables’ constituents. Suong has an education research focus, with significant experience in contributing to pharmacology education in the area of e-learning, assessment, and curriculum development. Overall, Suong has published over 50 research papers in high quality pharmacology/pharmacy journals. Currently, Suong is a Committee Member of the ASCEPT Clinical Pharmacology SIG, and she was a former Committee Member of the ASCEPT Equity, Diversity and Inclusion Committee.

Chang Nianwei, Lecturer. She received her Ph.D. in Chinese Materia Medica from Tianjin University of Traditional Chinese Medicine. She is currently a full-time faculty member in the Department of Pharmacology, School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine. Her research primarily focuses on the toxic and effective substances and mechanisms of traditional Chinese medicines for cardiovascular and cerebrovascular diseases. She serves as a Youth Committee Member of the Tianjin Pharmacological Society. She teaches courses including Pharmacology of Chinese Materia Medica, Pharmacology, and Drug Toxicology. She has published 6 papers as the first author or corresponding author, of which 5 are SCI-indexed papers. She has co-edited 3 books and filed 1 patent application as a key inventor.

Hee-Jin Oh, PhD, is a Professor in the Department of Medical Education at Daegu Catholic University School of Medicine, South Korea. She holds dual doctoral degrees in Medical Education and Medical Humanities, providing a unique interdisciplinary perspective on health professions education. As an active accreditor for the Korean Institute of Medical Education and Evaluation (KIMEE) and a consultant for the pharmacy accreditation board, she has been deeply involved in establishing competency-based standards. Her expertise focuses on Outcome-Based Education (OBE) and the systematic integration of humanities into clinical curricula.

HeeJin Oh, PhD, is a Professor in the Department of Medical Education at Daegu Catholic University School of Medicine. She holds dual doctoral degrees in Medical Education and Medical Humanities. As a leading expert, she serves as an accreditor for the Korean Institute of Medical Education and Evaluation (KIMEE) and a Board Member of the Korean Council on Health and Pharmaceutical Care for People with Disabilities (KCHPD). In this capacity, she leads the design and implementation of Disability Health Rights education for future health professionals. Her work focuses on bridging global competency standards with the systematic integration of medical humanities and social accountability into clinical education.

Dr. Zsófia Onódi is an assistant professor of Department of Pharmacology at Semmelweis University and the head of the Cardioimmunology Research Group. Her research focuses on cardiovascular immunology, concentrating on immune-inflammatory mechanisms in heart failure and other cardiac diseases, including inflammasome signaling, metabolic comorbidities, and pharmacological targeting of inflammatory pathways. In parallel with her research activity, Dr. Onódi is involved in medical education. She teaches pharmacology and clinical pharmacology at undergraduate and graduate levels and has led curriculum development projects introducing flipped-classroom methods and modern assessment strategies into pharmacology teaching. She also contributes to pharmacology textbooks and serves in educational and editorial roles in international pharmacological societies and journals.

Dr. Eunice Pak (MBBCh, AFHEA) is a specialised foundation programme resident doctor currently working at West Suffolk Hospital in the UK. She graduated from Cardiff University in July 2025 and aspires to pursue a career as a clinical academic. Throughout her medical school years, she was heavily involved in research projects and presented her work at national and international conferences, primarily in the areas of clinical pharmacology and paediatrics. Later in the year, Dr. Pak will undertake a four-month academic block at the University of Cambridge during her Foundation Year 2 training, focusing on medical oncology. She enjoys teaching, exploring new medical innovations, and engaging with medical humanities, including how medicine is applied in the fields of art, music, literature, and history. In her spare time, she enjoys hiking, watching tennis, singing, listening to music, playing board games, and maintaining her blogs. She is presenting two posters at the WCP: one titled “Is there a Difference in Odds Ratio between Quinolone Antibiotics and Associated Neuropsychiatric Adverse Events?”, which was a summer studentship project completed in 2024 and funded by the Wellcome Trust/Academy of Medical Sciences, and another innovative medical education project conducted in collaboration with professors from her university.

Xiang Dan, a Senior Nurse, graduated from Chongqing Medical University with a degree in Nursing in 2006. With two decades of dedicated experience in geriatric nursing, she is a multidisciplinary expert integrating clinical practice, teaching, research, and management.

Li Weiheng is a master student at Harbin Medical University (HMU) . During his last vacation, he gained hands-on research experience in a laboratory, where he mastered Western Blotting (WB) , including protein extraction and membrane imaging. This technical foundation fuels his interest in molecular biology. Beyond the lab, Weiheng actively participates in multiple academic competitions, which have honed his critical thinking, teamwork, and problem-solving skills under pressure. He is highly motivated to integrate experimental techniques with competitive innovation. His long-term goal is to advance biomedical research and contribute to clinical translation. He is now seeking further opportunities to deepen research training while maintaining excellence in coursework.

Li Yunyun, Associate Chief Physician, graduated from the Department of Anesthesiology at North Sichuan Medical College with a bachelor's degree, and is currently employed in the Anesthesiology Department of Yunyang County People's Hospital. She completed advanced training at the First Affiliated Hospital of Chongqing Medical University and the Children's Hospital of Chongqing Medical University. She specializes in various clinical anesthesia procedures and outpatient anesthesia services. She has led the implementation of one innovative technological project.

Attending Physician, Bachelor of Medicine, Member of the Communist Party of China. Graduated from the Department of Clinical Medicine (Specialization in Ophthalmology, Otorhinolaryngology) at North Sichuan Medical College. With over 10 years of clinical experience in ophthalmology, specializing in phacoemulsification with intraocular lens implantation for cataracts, correction of various types of entropion, and management of chronic fundus diseases.

Shan Xu is an Associate Chief Pharmacist and Deputy Director of GCP Institutional Office at The Second People’s Hospital of Changzhou, affiliated with Nanjing Medical University. She holds a Master’s degree in Pharmacology, and serves as postgraduate supervisor at Nanjing Medical University & Dalian Medical University, as well as adjunct associate professor at Changzhou University. She is recognized as Changzhou Health Young Talent. Her academic focuses lie in clinical rational drug use, oncology pharmacy, clinical pharmacology and pharmaceutical clinical trials. She acts as member of multiple national and provincial pharmaceutical professional committees, and leads anti-tumor drug standardized management work in local pharmaceutical quality control system.

Dr Lisa Kouladjian O'Donnell is a Senior Lecturer and credentialled pharmacist, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Australia. Lisa's research focuses on finding digital solutions to optimise medication management in older adults.